AI assistant
ORAGENICS INC — Director's Dealing 2011
Mar 15, 2011
35380_dirs_2011-03-15_b9d0f383-16d6-4149-81fa-d171510760e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (ORNI)
CIK: 0001174940
Period of Report: 2011-03-11
Reporting Person: Bohunicky Brian John (CFO, Secretary and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-11 | Common Stock | A | 10000 | — | Acquired | 22500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-11 | Employee Stock Option (Right to Buy) | $3.60 | A | 20000 | Acquired | 2021-03-10 | Common Stock (20000) | Direct |
Footnotes
F1: Such restricted stock will become vested as follows: one-half six months after the date of grant (9/11/2011), and one-half on the one-year anniversary of the date of grant (3/11/2012). Notwithstanding such time vesting, the restricted stock shall become immediately vested in full in the event of a change in control of the Company.
F2: Share amounts reflected are after adjustment for the Company's 1 for 20 reverse stock split that occurred September 24, 2010.
F3: Such stock option may be exercised as follows: one-third on the first anniversary of the date of grant (3/11/2012), with an additional one-third becoming exercisable on each of the following two anniversaries of the date of grant. Notwithstanding such time vesting, the options shall become immediately vested in full in the event of a change in control of the Company as specified in the stock option agreement between Mr. Bohunicky and the Company.